Superselective intraarterial fibrinolysis in central retinal artery occlusion

AJNR Am J Neuroradiol. 1999 Apr;20(4):565-7.

Abstract

Intraarterial fibrinolysis was performed in three patients with acute central retinal artery occlusion using recombinant tissue plasminogen activator as a fibrinolytic agent. In two cases the ophthalmic artery was selectively catheterized, and in the other a thrombolytic drug was infused into the ophthalmic artery by way of the meningeal collaterals. All patients experienced visual improvement. Fibrinolysis can produce better results than obtained from conservative treatment. A good prognosis can be achieved if the treatment starts within the first 4 to 5 hours after occlusion.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Blindness / therapy
  • Catheterization, Peripheral
  • Collateral Circulation / physiology
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Heparin / administration & dosage
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Injections, Intra-Arterial
  • Male
  • Meningeal Arteries
  • Middle Aged
  • Ophthalmic Artery
  • Prognosis
  • Retinal Artery Occlusion / drug therapy*
  • Thrombolytic Therapy / methods*
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Heparin
  • Tissue Plasminogen Activator